Both in Pharmaceuticals
Aquestive Therapeutics vs Arvinas
Over the past year AQST returned −37.1% and ARVN returned −20.0%; their daily moves had a correlation of 0.23.
AQST −37.1% ARVN −20.0%Growth of $1, one year, split-adjusted
| Metric | AQST | ARVN |
|---|---|---|
| Price | $4.23 | $7.60 |
| Market cap | $530.9M | $496.9M |
| Today | +3.93% | +2.01% |
| 1 month | −9.4% | +1.3% |
| 6 months | +4.4% | −22.6% |
| Year to date | −34.5% | −35.9% |
| 1 year | −39.6% | −21.2% |
| Revenue growth (YoY) | +38.1% | +1014.7% |
| Gross margin | 70.9% | 96.4% |
| Net margin | −165.5% | 67.8% |
| P/E (TTM) | — | 53.4× |
| Price / sales | 9.8× | 1.6× |
| Net cash | $47.8M | $567.6M |
| Dividend yield | — | — |
| Volatility (60d) | 55.8% | 48.4% |
| Short % of float | 25.6% | 10.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).